Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3998 | ICCC ImmuCell Corporation - Common Stock | 9.96 USD | -0.99% | +2.15% | -10.27% | +63.82% | 90.46 M USD | ||
| 4010 | RLYB Rallybio Corporation - Common Stock | 16.73 USD | -1.30% | -2.39% | +1.58% | +2598.39% | 88.84 M USD | ||
| 4021 | GANX Gain Therapeutics, Inc. - Common Stock | 1.98 USD | -1.49% | -4.81% | +10.61% | 0.00% | 86.41 M USD | ||
| 4033 | ACET Adicet Bio, Inc. - Common Stock | 8.95 USD | -2.61% | +2.05% | +13.43% | +1126.03% | 83.79 M USD | ||
| 4043 | TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.20 USD | +6.19% | +10.09% | +3.45% | -17.24% | 82.53 M USD | ||
| 4048 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.74 USD | -1.66% | -3.66% | -6.69% | -21.26% | 81.43 M USD | ||
| 4052 | MAIA MAIA Biotechnology, Inc. Common Stock | 1.35 USD | -2.88% | -2.88% | +4.65% | -35.10% | 82.11 M USD | ||
| 4060 | OKYO OKYO Pharma Limited - American Depositary Shares | 1.53 USD | -0.65% | -0.65% | -1.29% | -41.15% | 80.29 M USD | ||
| 4067 | ELOX Eloxx Pharmaceuticals, Inc. | 19.99 USD | -4.67% | +10.02% | +69.55% | +99.90% | 80.69 M USD | ||
| 4071 | CING Cingulate Inc. - Common Stock | 5.87 USD | +5.77% | +11.17% | +24.89% | -4.71% | 85.36 M USD | ||
| 4075 | ELTX Elicio Therapeutics, Inc. - Common Stock | 2.98 USD | -1.97% | -2.30% | -3.25% | -70.20% | 78.32 M USD | ||
| 4079 | GOSS Gossamer Bio, Inc. - Common Stock | 0.16 USD | +6.67% | +14.29% | -5.88% | -93.16% | 78.22 M USD | ||
| 4082 | CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 USD | +13.64% | +6.38% | +19.05% | -56.90% | 77.80 M USD | ||
| 4096 | NRXS Neuraxis, Inc. Common Stock | 6.10 USD | -0.81% | -3.02% | -9.09% | +12.34% | 76.60 M USD | ||
| 4099 | ANVS Annovis Bio, Inc. Common Stock | 1.77 USD | -2.75% | -3.80% | +5.99% | -25.94% | 75.41 M USD | ||
| 4105 | MNOV MediciNova, Inc. - Common Stock | 1.52 USD | +8.57% | +14.29% | +16.92% | +13.43% | 74.82 M USD | ||
| 4106 | SKYE Skye Bioscience, Inc. - Common Stock | 2.08 USD | +642.86% | +307.84% | +220.00% | +160.00% | 73.68 M USD | ||
| 4121 | SPRO Spero Therapeutics, Inc. - Common Stock | 1.24 USD | +1.64% | +1.64% | +1.64% | -34.39% | 72.21 M USD | ||
| 4124 | PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.34 USD | +0.75% | +6.35% | +8.06% | -10.07% | 71.63 M USD | ||
| 4125 | SER Serina Therapeutics, Inc. Common Stock | 2.80 USD | -2.44% | +3.32% | +40.00% | +67.66% | 71.12 M USD |
Nachrichten Biotechnology Stocks
Alto Neuroscience Aktie erreicht Allzeithoch bei 35,42 USD
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.08 | +642.86% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0026 | +160.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.65 | +20.44% |
APRE Aprea Therapeutics, Inc. - Common Stock | 0.75 | +17.19% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.81 | +16.77% |
BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.1201 | +14.38% |
CRDF Cardiff Oncology, Inc. - Common Stock | 1.00 | +13.64% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0045 | -50.00% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 7.84 | -26.87% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.09 | -18.17% |
ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.14 | -16.19% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTXL BriaCell Therapeutics Corp. - Warrants | 0.9500 | -12.04% |